Estrogen replacement: the evolving role of alternative delivery systems. Introduction
Lobo, R.A.
American Journal of Obstetrics and Gynecology 173(3 Pt 2): 981
1995
ISSN/ISBN: 0002-9378 PMID: 7573294 Document Number: 448310
Document emailed within 1 workday
Related Documents
Ohta, H. 2008: Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis Clinical Calcium 18(10): 1442-1450Dalton, J.J. 1987: Alternative delivery systems and employers Topics in Health Care Financing 13(3): 68-76
Soroka, M. 1989: Alternative delivery systems and managed care Journal of the American Optometric Association 60(11): 799-800
Baer, R.K. 1985: Alternative delivery systems of health care Topics in Health Care Financing 12(1): 56-63
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Kucera, W.R.; Marren, J.P. 1987: Guidelines for physician contracting with alternative delivery systems Journal of Medical Practice Management: Mpm 2(3): 200-206
Toohey, E.M.; Shillinger, F.L.; Baranowski, S.L. 1985: Planning alternative delivery systems. An organizational assessment Journal of Nursing Administration 15(12): 9-15
Ghaturvedi, S.; Chaturvedi, S. 1997: Non-clinical delivery systems: an alternative approach for distribution of iron and folic acid tablets Journal of the Indian Medical Association 95(4): 118
Csaba, N.; Alonso, M.J. 2014: 12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) Journal of Controlled Release: Official Journal of the Controlled Release Society 190: 53-54
1987: Nutrition services in health maintenance organizations and alternative health care delivery systems: technical support paper Journal of the American Dietetic Association 87(10): 1392-1393
Hogan, B. 2006: The role of filtration in drug delivery systems Medical Device Technology 17(5): 22-24
Slater, C.C.; Zhang, C.; Hodis, H.N.; Mack, W.J.; Boostanfar, R.; Shoupe, D.; Paulson, R.J.; Stanczyk, F.Z. 2001: Comparison of estrogen and androgen levels after oral estrogen replacement therapy Journal of Reproductive Medicine 46(12): 1052-1056
Cason, Z.; Tucci, M.; England, B.; Benghuzzi, H. 1997: Pathophysiological changes associated with sustained delivery of estrogen and estrogen plus progesterone by TCPL devices Biomedical Sciences Instrumentation 34: 24-29
Dargent, D. 2000: Estrogen replacement therapy in patients in remission after treatment for estrogen dependent cancer. Certainties are still lacking Gynecologie Obstetrique and Fertilite 28(6): 427-428
Thow, J.C. 1991: Progress in alternative methods of insulin substitution? Tenth workshop of the AIDSPIT Study Group. Artificial Insulin Delivery Systems Pancreas and Islet Transplantation Diabetic Medicine: a Journal of the British Diabetic Association 8(7): 691-692
Silverman, M.W. 1989: Optometry and its expanded role in health care delivery systems (1600-1987) Journal of the American Optometric Association 60(1): 52-55
Byrd, K.; Benghuzzi, H. 2000: The role of density on the release profiles of hydrophobic and hydrophilic compounds from TCPL delivery systems Biomedical Sciences Instrumentation 36: 165-170
Kruk, M.E.; Prescott, M.R. 2012: The role of health systems and policies in promoting safe delivery in low- and middle-income countries: a multilevel analysis American Journal of Public Health 102(4): 645-650
Papakonstantinou, D.; Malamateniou, F.; Vassilacopoulos, G. 2008: Using ESB and BPEL for evolving healthcare systems towards SOA Studies in Health Technology and Informatics 136: 747-752
Foldvari, M.; Baca-Estrada, M.E.; He, Z.; Hu, J.; Attah-Poku, S.; King, M. 1999: Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha Biotechnology and Applied Biochemistry 30(2): 129-137